Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
暂无分享，去创建一个
A. Mestrovic | N. Chng | S. Tyldesley | Mitchell C C Liu | H. Pai | P. Basran | R. Olson | A. Bergman | D. Schellenberg | F. Hsu | D. Hyde | D. Glick | B. Mou | T. Berrang | Q. Matthews | B. Valev | H. Carolan | C. Lund | S. Lam | Shilo Lefresene